Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line

Zhao, Y; Mao, YS; He, J; Gao, SG; Zhang, ZR; Ding, NN; Xue, Q; Gao, YS; Wang, DL; Zhao, J; Tan, FW; Yuan, LG; Li, F; Wang, SB; Yang, L

Mao, YS (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Thorac Surg, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.

CLINICAL LUNG CANCER, 2021; 22 (2): E201

Abstract

We studied the effect of any steroid use in patients with advanced non-small-cell lung cancer receiving immunotherapy with first-line pembrolizumab, a......

Full Text Link